Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy

  title={Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy},
  author={E. Raymond and S. Faivre and J. Armand},
  • E. Raymond, S. Faivre, J. Armand
  • Published 2012
  • Medicine, Biology
  • Drugs
  • Increasing knowledge of the structure and function of the epidermal growth factor receptor (EGFR) subfamily of tyrosine kinases and of their role in the initiation and progression of various cancers has, in recent years, provided the impetus for a substantial research effort aimed at developing new anticancer therapies that target specific components of the EGFR signal transduction pathway. Selective compounds have been developed that target either the extracellular ligand-binding region of the… CONTINUE READING
    169 Citations
    PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor
    • 14
    Tyrosine kinase, aurora kinase and leucine aminopeptidase as attractive drug targets in anticancer therapy - characterisation of their inhibitors.
    • 3
    • PDF
    EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells.
    Autophosphorylation activation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes
    • 6
    33 EGFR as a therapeutic target in glioblastoma


    Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.
    • 65
    • Highly Influential
    Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
    • G. Kelloff, J. R. Fay, +4 authors C. Sigman
    • Chemistry, Medicine
    • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
    • 1996
    • 89
    • Highly Influential
    • PDF
    Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors.
    • D. Fry
    • Medicine, Biology
    • Pharmacology & therapeutics
    • 1999
    • 123
    • Highly Influential
    EGF receptor.
    • A. Wells
    • Medicine
    • The international journal of biochemistry & cell biology
    • 1999
    • 600
    Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells.
    • 77
    Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
    • 380
    • PDF
    Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.
    • J. Mendelsohn
    • Medicine, Biology
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 1997
    • 327
    • PDF
    The epidermal growth factor receptor and its inhibition in cancer therapy.
    • 795
    • Highly Influential